-
Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment The EARLY Randomized TrialG Lemesle, M Laine, M Pankert et al. -
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus StatementPB Shah, FGP Welt, E Mahmud et al.
-
Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based StudyR Asleh, M Enriquez-Sarano, AS Jaffe et al.
-
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical TrialWang TY, Kaltenbach LA, Cannon CP et al.
-
Multivessel PCI Guided by FFR or Angiography for Myocardial InfarctionE Puymirat, G Cayla, for the FLOWER-MI Study Investigators et al.
-
Optimal medical therapy vs. coronary revascularization for patients presenting with chronic total occlusion: A meta-analysis of randomized controlled trials and propensity score adjusted studiesIannaccone M, D'ascenzo F, Piazza F et al.
-
Prevalence of Coronary Vasospasm Using Coronary Reactivity Testing in Patients With Spontaneous Coronary Artery DissectionSolaru KW, Heupler F, Kim ESH et al.
-
Deficiency of GATA3-Positive Macrophages Improves Cardiac Function Following Myocardial Infarction or Pressure Overload HypertrophyMJ Yang, L Song, L Wang et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
